Planet MicroCap Showcase: VEGAS 2025
Logotype for NEXGEL Inc

NEXGEL (NXGL) Planet MicroCap Showcase: VEGAS 2025 summary

Event summary combining transcript, slides, and related documents.

Logotype for NEXGEL Inc

Planet MicroCap Showcase: VEGAS 2025 summary

3 Feb, 2026

Business overview and growth strategy

  • Operates in three divisions: consumer products, contract manufacturing, and medical devices, with a focus on hydrogel technology for medical and cosmetic applications.

  • Expanded customer base includes major healthcare and consumer companies, fueling over 100% year-over-year growth for the past three years.

  • Facility in Pennsylvania features a rare electron beam accelerator for hydrogel production; packaging operations expanded in Texas with a new clean room.

  • Strategic partnerships and acquisitions, such as Kenkoderm and Silly George, have driven product and revenue diversification.

  • No company debt, with a focus on reducing cash burn and approaching EBITDA positive status.

Product innovation and pipeline

  • Medical device pipeline includes time-release drug patches and a human trial for an Apremilast patch targeting stubborn psoriasis lesions.

  • Consumer brands include MediGel, Kenkoderm (expanding to eczema products), and Silly George (eyelash and beauty products), with significant sales growth and new product launches planned.

  • SilverSeal, an antimicrobial wound and burn product, is now distributed through Cintas, increasing brand recognition and recurring revenue.

  • Partnership with STADA has exceeded projections, with new product launches and a growing U.S. platform.

  • Supplying gel pads for AbbVie's RESONIC cellulite treatment, with future revenue potential as the product launches.

Market positioning and competitive advantages

  • High water content, biocompatible hydrogels differentiate the company from competitors, making it the default choice for sensitive skin and medical applications.

  • U.S. manufacturing and tariff changes have made products more competitive against foreign UV gel manufacturers.

  • Custom and white label manufacturing offers expansion opportunities for partners in dermatology, beauty, and drug delivery markets.

  • Ongoing studies and commercial orders for gels used in laser hair removal and carcinogenic plume reduction, with potential for broader applications.

  • Marketing strategies are platform-specific, leveraging in-house analytics and external agencies to optimize direct-to-consumer sales.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more